Revolutionizing Pediatric Care: Approval of Mal...

By João L. Carapinha

July 10, 2025

Novartis recently announced that it has received approval for the first malaria medicine for newborns, specifically developed for babies and young infants. This groundbreaking development targets a vulnerable population that has historically had l...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.